-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Did you know that cancer is the leading cause of death in dogs over the age of two? 50% of all dogs will be diagnosed with cancer in their lifetimes. As with humans, early detection is key for better outcomes in these dogs. Watch this short video, featuring Volition CMO Heather Wilson-Robles, as she introduces our Nu.Q® Vet Cancer Test and its benefits.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields